Diag-Nose.io was founded as a spin-out from the Stanford Medicine ENT Innovation program to address unmet diagnostic needs for rhinology and ENT applications.We are developing precision medicine tools to provide otolaryngologists (Ear, Nose, Throat surgeons) with actionable clinical insights and help them better prescribe therapies for patientswith sinonasal conditions.Our primary focus is Chronic Rhinosinusitis (CRS). We are creating a first-in-class chronic sinusitis clinical decision support system consisting of a multiplexed platform that combines protein biomarkers, digital biomarkers and multivariate algorithms to create actionable clinical insights for the patients sinonasal condition. The system aims to provide diagnostic clarity around overlapping sinonasal conditions so the physician can administer the appropriate treatment, monitor their efficacy and reduce unnecessary interventions/therapy.

Biotechnology

Health Care

Health Diagnostics

Diag-Nose.io

Diag-Nose.io's headquarters in Melbourne, Australia

Diag-Nose.io

Org chart

Teams

Offices

Similar companies